Asia-Pacific Biosimilar Market Report 2017

August 2017 | 105 pages | ID: A477BFC6F25EN
QYResearch

Abstracts

In this report, the Asia-Pacific Biosimilar market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Biosimilar for these regions, from 2012 to 2022 (forecast), including

• China
• Japan
• South Korea
• Taiwan
• India
• Southeast Asia
• Australia

Asia-Pacific Biosimilar market competition by top manufacturers/players, with Biosimilar sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• Roche
• Eli Lilly
• Bayer
• Amgen
• Sanofi-Aventis
• Johnson & Johnson
• Novo Nordisk
• Merck

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Antibody
• Hormone
• Growth Factors
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Biosimilar for each application, includin

• Tumor
• Diabetes
• Cardiovascular
• Hemophilia
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Asia-Pacific Biosimilar Market Report 2017

1 BIOSIMILAR OVERVIEW

1.1 Product Overview and Scope of Biosimilar
1.2 Classification of Biosimilar by Product Category
  1.2.1 Asia-Pacific Biosimilar Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Biosimilar Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Antibody
  1.2.4 Hormone
  1.2.5 Growth Factors
  1.2.6 Other
1.3 Asia-Pacific Biosimilar Market by Application/End Users
  1.3.1 Asia-Pacific Biosimilar Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Tumor
  1.3.3 Diabetes
  1.3.4 Cardiovascular
  1.3.5 Hemophilia
  1.3.6 Other
1.4 Asia-Pacific Biosimilar Market by Region
  1.4.1 Asia-Pacific Biosimilar Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Biosimilar (2012-2022)
  1.5.1 Asia-Pacific Biosimilar Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Biosimilar Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC BIOSIMILAR COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Biosimilar Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Biosimilar Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Biosimilar Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Biosimilar (Volume and Value) by Type
  2.2.1 Asia-Pacific Biosimilar Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Biosimilar Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Biosimilar (Volume) by Application
2.4 Asia-Pacific Biosimilar (Volume and Value) by Region
  2.4.1 Asia-Pacific Biosimilar Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Biosimilar Revenue and Market Share by Region (2012-2017)

3 CHINA BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

3.1 China Biosimilar Sales and Value (2012-2017)
  3.1.1 China Biosimilar Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Biosimilar Revenue and Growth Rate (2012-2017)
  3.1.3 China Biosimilar Sales Price Trend (2012-2017)
3.2 China Biosimilar Sales Volume and Market Share by Type
3.3 China Biosimilar Sales Volume and Market Share by Application

4 JAPAN BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Biosimilar Sales and Value (2012-2017)
  4.1.1 Japan Biosimilar Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Biosimilar Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Biosimilar Sales Price Trend (2012-2017)
4.2 Japan Biosimilar Sales Volume and Market Share by Type
4.3 Japan Biosimilar Sales Volume and Market Share by Application

5 SOUTH KOREA BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Biosimilar Sales and Value (2012-2017)
  5.1.1 South Korea Biosimilar Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Biosimilar Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Biosimilar Sales Price Trend (2012-2017)
5.2 South Korea Biosimilar Sales Volume and Market Share by Type
5.3 South Korea Biosimilar Sales Volume and Market Share by Application

6 TAIWAN BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Biosimilar Sales and Value (2012-2017)
  6.1.1 Taiwan Biosimilar Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Biosimilar Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Biosimilar Sales Price Trend (2012-2017)
6.2 Taiwan Biosimilar Sales Volume and Market Share by Type
6.3 Taiwan Biosimilar Sales Volume and Market Share by Application

7 INDIA BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

7.1 India Biosimilar Sales and Value (2012-2017)
  7.1.1 India Biosimilar Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Biosimilar Revenue and Growth Rate (2012-2017)
  7.1.3 India Biosimilar Sales Price Trend (2012-2017)
7.2 India Biosimilar Sales Volume and Market Share by Type
7.3 India Biosimilar Sales Volume and Market Share by Application

8 SOUTHEAST ASIA BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Biosimilar Sales and Value (2012-2017)
  8.1.1 Southeast Asia Biosimilar Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Biosimilar Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Biosimilar Sales Price Trend (2012-2017)
8.2 Southeast Asia Biosimilar Sales Volume and Market Share by Type
8.3 Southeast Asia Biosimilar Sales Volume and Market Share by Application

9 AUSTRALIA BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Biosimilar Sales and Value (2012-2017)
  9.1.1 Australia Biosimilar Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Biosimilar Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Biosimilar Sales Price Trend (2012-2017)
9.2 Australia Biosimilar Sales Volume and Market Share by Type
9.3 Australia Biosimilar Sales Volume and Market Share by Application

10 ASIA-PACIFIC BIOSIMILAR PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Pfizer
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Biosimilar Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Pfizer Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Roche
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Biosimilar Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Roche Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Eli Lilly
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Biosimilar Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Eli Lilly Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Bayer
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Biosimilar Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Bayer Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Amgen
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Biosimilar Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Amgen Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Sanofi-Aventis
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Biosimilar Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Sanofi-Aventis Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Johnson & Johnson
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Biosimilar Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Johnson & Johnson Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Novo Nordisk
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Biosimilar Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Novo Nordisk Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Merck
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Biosimilar Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Merck Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview

11 BIOSIMILAR MANUFACTURING COST ANALYSIS

11.1 Biosimilar Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Biosimilar

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Biosimilar Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Biosimilar Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC BIOSIMILAR MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Biosimilar Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Biosimilar Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Biosimilar Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Biosimilar Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Biosimilar Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Biosimilar Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Biosimilar Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Biosimilar Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Biosimilar Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Biosimilar Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Biosimilar Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Biosimilar Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Biosimilar Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Biosimilar Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Biosimilar Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Biosimilar Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Biosimilar Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Biosimilar Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Biosimilar Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Biosimilar
Figure Asia-Pacific Biosimilar Sales Volume (K Units) by Type (2012-2022)
Figure Asia-Pacific Biosimilar Sales Volume Market Share by Type (Product Category) in 2016
Figure Antibody Product Picture
Figure Hormone Product Picture
Figure Growth Factors Product Picture
Figure Other Product Picture
Figure Asia-Pacific Biosimilar Sales (K Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Biosimilar by Application in 2016
Figure Tumor Examples
Table Key Downstream Customer in Tumor
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Cardiovascular Examples
Table Key Downstream Customer in Cardiovascular
Figure Hemophilia Examples
Table Key Downstream Customer in Hemophilia
Figure Other Examples
Table Key Downstream Customer in Other
Figure Asia-Pacific Biosimilar Market Size (Million USD) by Region (2012-2022)
Figure China Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Biosimilar Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Asia-Pacific Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Biosimilar Market Major Players Product Sales Volume (K Units)(2012-2017)
Table Asia-Pacific Biosimilar Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Biosimilar Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Biosimilar Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Biosimilar Sales Share by Players/Suppliers
Figure Asia-Pacific Biosimilar Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Biosimilar Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Biosimilar Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Biosimilar Revenue Share by Players
Figure 2017 Asia-Pacific Biosimilar Revenue Share by Players
Table Asia-Pacific Biosimilar Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Biosimilar Sales Share by Type (2012-2017)
Figure Sales Market Share of Biosimilar by Type (2012-2017)
Figure Asia-Pacific Biosimilar Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Biosimilar Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Biosimilar Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biosimilar by Type (2012-2017)
Figure Asia-Pacific Biosimilar Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Biosimilar Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Asia-Pacific Biosimilar Sales Share by Region (2012-2017)
Figure Sales Market Share of Biosimilar by Region (2012-2017)
Figure Asia-Pacific Biosimilar Sales Market Share by Region in 2016
Table Asia-Pacific Biosimilar Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Biosimilar Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Biosimilar by Region (2012-2017)
Figure Asia-Pacific Biosimilar Revenue Market Share by Region in 2016
Table Asia-Pacific Biosimilar Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific Biosimilar Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Biosimilar Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Biosimilar Sales Market Share by Application (2012-2017)
Figure China Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure China Biosimilar Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Biosimilar Sales Price (USD/Unit) Trend (2012-2017)
Table China Biosimilar Sales Volume (K Units) by Type (2012-2017)
Table China Biosimilar Sales Volume Market Share by Type (2012-2017)
Figure China Biosimilar Sales Volume Market Share by Type in 2016
Table China Biosimilar Sales Volume (K Units) by Applications (2012-2017)
Table China Biosimilar Sales Volume Market Share by Application (2012-2017)
Figure China Biosimilar Sales Volume Market Share by Application in 2016
Figure Japan Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Biosimilar Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Biosimilar Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Biosimilar Sales Volume (K Units) by Type (2012-2017)
Table Japan Biosimilar Sales Volume Market Share by Type (2012-2017)
Figure Japan Biosimilar Sales Volume Market Share by Type in 2016
Table Japan Biosimilar Sales Volume (K Units) by Applications (2012-2017)
Table Japan Biosimilar Sales Volume Market Share by Application (2012-2017)
Figure Japan Biosimilar Sales Volume Market Share by Application in 2016
Figure South Korea Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea Biosimilar Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Biosimilar Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea Biosimilar Sales Volume (K Units) by Type (2012-2017)
Table South Korea Biosimilar Sales Volume Market Share by Type (2012-2017)
Figure South Korea Biosimilar Sales Volume Market Share by Type in 2016
Table South Korea Biosimilar Sales Volume (K Units) by Applications (2012-2017)
Table South Korea Biosimilar Sales Volume Market Share by Application (2012-2017)
Figure South Korea Biosimilar Sales Volume Market Share by Application in 2016
Figure Taiwan Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan Biosimilar Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Biosimilar Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan Biosimilar Sales Volume (K Units) by Type (2012-2017)
Table Taiwan Biosimilar Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Biosimilar Sales Volume Market Share by Type in 2016
Table Taiwan Biosimilar Sales Volume (K Units) by Applications (2012-2017)
Table Taiwan Biosimilar Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Biosimilar Sales Volume Market Share by Application in 2016
Figure India Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure India Biosimilar Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Biosimilar Sales Price (USD/Unit) Trend (2012-2017)
Table India Biosimilar Sales Volume (K Units) by Type (2012-2017)
Table India Biosimilar Sales Volume Market Share by Type (2012-2017)
Figure India Biosimilar Sales Volume Market Share by Type in 2016
Table India Biosimilar Sales Volume (K Units) by Application (2012-2017)
Table India Biosimilar Sales Volume Market Share by Application (2012-2017)
Figure India Biosimilar Sales Volume Market Share by Application in 2016
Figure Southeast Asia Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Biosimilar Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Biosimilar Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Biosimilar Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Biosimilar Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Biosimilar Sales Volume Market Share by Type in 2016
Table Southeast Asia Biosimilar Sales Volume (K Units) by Applications (2012-2017)
Table Southeast Asia Biosimilar Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Biosimilar Sales Volume Market Share by Application in 2016
Figure Australia Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Australia Biosimilar Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Biosimilar Sales Price (USD/Unit) Trend (2012-2017)
Table Australia Biosimilar Sales Volume (K Units) by Type (2012-2017)
Table Australia Biosimilar Sales Volume Market Share by Type (2012-2017)
Figure Australia Biosimilar Sales Volume Market Share by Type in 2016
Table Australia Biosimilar Sales Volume (K Units) by Applications (2012-2017)
Table Australia Biosimilar Sales Volume Market Share by Application (2012-2017)
Figure Australia Biosimilar Sales Volume Market Share by Application in 2016
Table Pfizer Biosimilar Basic Information List
Table Pfizer Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Biosimilar Sales Market Share in Asia-Pacific (2012-2017)
Figure Pfizer Biosimilar Revenue Market Share in Asia-Pacific (2012-2017)
Table Roche Biosimilar Basic Information List
Table Roche Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Roche Biosimilar Sales Market Share in Asia-Pacific (2012-2017)
Figure Roche Biosimilar Revenue Market Share in Asia-Pacific (2012-2017)
Table Eli Lilly Biosimilar Basic Information List
Table Eli Lilly Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Eli Lilly Biosimilar Sales Market Share in Asia-Pacific (2012-2017)
Figure Eli Lilly Biosimilar Revenue Market Share in Asia-Pacific (2012-2017)
Table Bayer Biosimilar Basic Information List
Table Bayer Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Bayer Biosimilar Sales Market Share in Asia-Pacific (2012-2017)
Figure Bayer Biosimilar Revenue Market Share in Asia-Pacific (2012-2017)
Table Amgen Biosimilar Basic Information List
Table Amgen Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Amgen Biosimilar Sales Market Share in Asia-Pacific (2012-2017)
Figure Amgen Biosimilar Revenue Market Share in Asia-Pacific (2012-2017)
Table Sanofi-Aventis Biosimilar Basic Information List
Table Sanofi-Aventis Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi-Aventis Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi-Aventis Biosimilar Sales Market Share in Asia-Pacific (2012-2017)
Figure Sanofi-Aventis Biosimilar Revenue Market Share in Asia-Pacific (2012-2017)
Table Johnson & Johnson Biosimilar Basic Information List
Table Johnson & Johnson Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Johnson & Johnson Biosimilar Sales Market Share in Asia-Pacific (2012-2017)
Figure Johnson & Johnson Biosimilar Revenue Market Share in Asia-Pacific (2012-2017)
Table Novo Nordisk Biosimilar Basic Information List
Table Novo Nordisk Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novo Nordisk Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Novo Nordisk Biosimilar Sales Market Share in Asia-Pacific (2012-2017)
Figure Novo Nordisk Biosimilar Revenue Market Share in Asia-Pacific (2012-2017)
Table Merck Biosimilar Basic Information List
Table Merck Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Merck Biosimilar Sales Market Share in Asia-Pacific (2012-2017)
Figure Merck Biosimilar Revenue Market Share in Asia-Pacific (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar
Figure Manufacturing Process Analysis of Biosimilar
Figure Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of Biosimilar Major Manufacturers in 2016
Table Major Buyers of Biosimilar
Table Distributors/Traders List
Figure Asia-Pacific Biosimilar Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Biosimilar Price (USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific Biosimilar Sales Volume (K Units) Forecast by Region (2017-2022)
Figure Asia-Pacific Biosimilar Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Biosimilar Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Biosimilar Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Biosimilar Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Biosimilar Revenue Market Share Forecast by Region in 2022
Figure China Biosimilar Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure China Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Biosimilar Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Biosimilar Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure South Korea Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Biosimilar Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Biosimilar Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure India Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Biosimilar Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Biosimilar Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Australia Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Biosimilar Sales (K Units) Forecast by Type (2017-2022)
Figure Asia-Pacific Biosimilar Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Biosimilar Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Biosimilar Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Biosimilar Price (USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific Biosimilar Sales (K Units) Forecast by Application (2017-2022)
Figure Asia-Pacific Biosimilar Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources